Surrozen, Inc.
SRZN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001824893
In the last 90 days, Surrozen, Inc. insiders filed 0 open-market purchases and 1 sale; 70 institutions reported holding it in 13F filings for Q2 2026, worth $314.5M in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Surrozen, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −3 vs. Q4 2022
- Shares held
- 16.5M
- +380.5K (+2.4%) vs. Q4 2022
- Total value
- $9.91M
- +$552.4K (+5.9%) vs. Q4 2022
- New holders
- 1
- 7 more added
- Sold out
- 4
- 1 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SRZN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 70 | $314.5M |
| Q1 2026 | 59 | $314.2M |
| Q4 2025 | 55 | $195.1M |
| Q3 2025 | 36 | $81.7M |
| Q2 2025 | 31 | $53.9M |
| Q1 2025 | 30 | $63.5M |
| Q4 2024 | 24 | $35.4M |
| Q3 2024 | 23 | $25.5M |
| Q2 2024 | 21 | $23.1M |
| Q1 2024 | 16 | $15.0M |
| Q4 2023 | 17 | $9.78M |
| Q3 2023 | 25 | $7.90M |
| Q2 2023 | 22 | $8.62M |
| Q1 2023 | 23 | $9.91M |
| Q4 2022 | 26 | $9.36M |
| Q3 2022 | 27 | $44.1M |
| Q2 2022 | 24 | $63.1M |
| Q1 2022 | 30 | $67.4M |
| Q4 2021 | 32 | $153.5M |
| Q3 2021 | 29 | $150.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Surrozen, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 148 | $89 | 0.00% | +2+1.4% | Added |
| Wolverine Asset Management LLC | 7,725 | $4.65K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 15,250 | $9.18K | 0.00% | +13,375+713.3% | Added |
| Tower Research Capital LLC (TRC) | 17,188 | $10.0K | 0.00% | +6,523+61.2% | Added |
| Virtu Financial LLC | 35,316 | $21.0K | 0.00% | +24,490+226.2% | Added |
| Northern Trust Corp | 35,833 | $21.6K | 0.00% | 00.0% | Unchanged |
| Jasper Ridge Partners, L.P. | 46,838 | $28.2K | 0.00% | 00.0% | Unchanged |
| Bridger Management, LLC | 61,699 | $37.1K | 0.01% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 61,699 | $37.1K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 70,932 | $42.7K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 86,430 | $52.0K | 0.00% | +1,608+1.9% | Added |
| Renaissance Technologies LLC | 102,298 | $62.0K | 0.00% | +75,700+284.6% | Added |
| Geode Capital Management, LLC | 171,950 | $103.5K | 0.00% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 300,000 | $180.6K | 0.04% | 00.0% | Unchanged |
| Alyeska Investment Group, L.P. | 305,648 | $184.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 487,698 | $293.6K | 0.00% | 00.0% | Unchanged |
| Trustees of Columbia University in the City of New York | 718,950 | $432.8K | 0.77% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 781,960 | $470.7K | 0.04% | 00.0% | Unchanged |
| Morgan Stanley | 789,870 | $475.5K | 0.00% | +261,691+49.5% | Added |
| Euclidean Capital LLC | 802,963 | $483.4K | 0.42% | 00.0% | Unchanged |
| Harvard Management Co Inc | 826,852 | $497.8K | 0.05% | 00.0% | Unchanged |
| BML Capital Management, LLC | 1,494,037 | $899.4K | 0.78% | +1,494,037 | New |
| The Column Group LLC | 9,248,129 | $5.57M | 2.01% | −166,666−1.8% | Reduced |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 0 | $0 | 0.00% | −1,161,400−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −123,464−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −45,360−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −22−100.0% | Sold out |